45
Epidemiology of Drug Use Brian J. Piper, Ph.D.

Neuropharmacology: Epidemiology

Embed Size (px)

DESCRIPTION

Lecture 10 from a college level neuropharmacology course taught in the spring 2012 semester by Brian J. Piper, Ph.D. ([email protected]) at Willamette University. Focus is on the Monitoring the Future.

Citation preview

Page 1: Neuropharmacology: Epidemiology

Epidemiology of Drug Use

Brian J. Piper, Ph.D.

Page 2: Neuropharmacology: Epidemiology

Epidemiology

• Study of diseases in population• Descriptive, not inferential (+ who, - why)

– Nitrites “poppers”– LSD

http://bmj.bmjjournals.com/epidem/epid.1.html

Page 3: Neuropharmacology: Epidemiology

Goals

• Monitoring the Future (MtF): self-report survey of 8th - 12th grades

• National Household Survey of Drug Use and Health (NHSDUH): interviews of age 12+

• Drug Abuse Warning Network (DAWN): ER reports

• United Nations World Drug Report

http://www.monitoringthefuture.org/http://www.oas.samhsa.gov/public.cfm

Page 4: Neuropharmacology: Epidemiology

Monitoring the Future

• National survey, conducted annually by NIDA of secondary school (8th, 10th, or 12th), college students, and adults (<45 yrs)

• Missing data (drop-outs = 15%, not attending) = under-estimation

• Concern about labels (inadvertent marketing)• Self-report

– Knowledge (e.g. steroids, diet pills, club drugs)– Memory (e.g. How many drinks?)– Taboo

http://www.monitoringthefuture.org/

Page 5: Neuropharmacology: Epidemiology

Demographics

• Compares use by:– Year (1975 – present)– Sex– Ethnicity– Parental education– Region– College plans

?

Page 6: Neuropharmacology: Epidemiology
Page 7: Neuropharmacology: Epidemiology

Year & Grade

Illicit = Scheduled drugs including marijuana, heroin, cocaine, methamphetamine, LSDNot Illicit: EtOH, cigarettes, inhalants, Ritalin for medical purposes

Page 8: Neuropharmacology: Epidemiology
Page 9: Neuropharmacology: Epidemiology

When does use start?

Page 10: Neuropharmacology: Epidemiology
Page 11: Neuropharmacology: Epidemiology
Page 12: Neuropharmacology: Epidemiology

What about ethnicity?

• Ranking:– African-American– Hispanic– White

Page 13: Neuropharmacology: Epidemiology
Page 14: Neuropharmacology: Epidemiology
Page 15: Neuropharmacology: Epidemiology
Page 16: Neuropharmacology: Epidemiology
Page 17: Neuropharmacology: Epidemiology

Subjective Effects

AlcoholAmphetaminesCocaineHeroinLSDMarijuanaOther HallucinogensOther Narcotics

Page 18: Neuropharmacology: Epidemiology

Subjective Effects

Page 19: Neuropharmacology: Epidemiology
Page 20: Neuropharmacology: Epidemiology
Page 21: Neuropharmacology: Epidemiology

Young Adults: 19-30

Page 22: Neuropharmacology: Epidemiology

How do college student differ from others in Alcohol and Nicotine Use?

Page 23: Neuropharmacology: Epidemiology

How do college student differ from others in Alcohol and Nicotine Use?

Page 24: Neuropharmacology: Epidemiology

D.A.R.E.

• Founded in 1983 by Daryl Gates• Police officers give lectures to middle school• Found in 80% of U.S. school districts, 54

nations• Cohen’s d = (MeanD.A.R.E. – MeanControl )/ SDpop

d = 0.30 small, 0.50 medium, 0.70 large

http://www.dare.com/home/default.asp

Page 25: Neuropharmacology: Epidemiology

Does D.A.R.E work?

Ennett S.T. (1994). American Journal of Public Health, 84, 1394-1401.

Page 26: Neuropharmacology: Epidemiology

National Household Surveyon Drug Use & Health

• Face to Face 4 hour Interview (N=4,500)

• Nationally representative

• Excludes prisoners, transients

• Statistical Significance: *p < .05

• But clinical (real world) significance?

https://nsduhweb.rti.org/

Page 27: Neuropharmacology: Epidemiology
Page 28: Neuropharmacology: Epidemiology
Page 29: Neuropharmacology: Epidemiology
Page 30: Neuropharmacology: Epidemiology
Page 31: Neuropharmacology: Epidemiology
Page 32: Neuropharmacology: Epidemiology
Page 33: Neuropharmacology: Epidemiology

Treatment Options

Page 34: Neuropharmacology: Epidemiology

Treatment Options

Page 35: Neuropharmacology: Epidemiology

Drug Abuse Warning Network

• Nationwide reports of ER/ED visits

• 242 hospitals nationwide

• Drug is “implicated”– Overdose– Suicide– Accident

Page 36: Neuropharmacology: Epidemiology

2009

http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm

Page 37: Neuropharmacology: Epidemiology

http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm

Page 38: Neuropharmacology: Epidemiology

EthnicityAlcohol Illicit

White 59.6% 50.1%

Black 19.2% 26.9%

Hispanic 12.4% 13.1%

Other/Unknown 8.8% 9.9%

http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm

Page 39: Neuropharmacology: Epidemiology

EthnicityAlcohol Illicit National (2010 Census)

White 59.6% 50.1% 63.7%

Black 19.2% 26.9% 12.6%

Hispanic 12.4% 13.1% 16.3%

Other/Unknown 8.8% 9.9% 7.4%

http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm

Page 40: Neuropharmacology: Epidemiology

UNWDR

• United Nations World Drug Report

• Pooled data from various countries with various methods

• Provides information about drug use, treatment, and drug seizures

Page 41: Neuropharmacology: Epidemiology

Annual Use

Page 42: Neuropharmacology: Epidemiology
Page 43: Neuropharmacology: Epidemiology

Injection Drug Use

Page 44: Neuropharmacology: Epidemiology

Summary

• Data Sources:– Monitoring the Future (Survey)

– National Household Survey on Drug Use & Health (Interview)

– Drug Abuse Warning Network (ED)

– Patterns: • Year• Age• Ethnicity• Other: College Plans

Page 45: Neuropharmacology: Epidemiology

Thought question

• Design an empirically based drug education program for high-school students.– What drugs would you target?– What ages?– Would ethnicity or other factors be involved in

your design making process?

http://learn.genetics.utah.edu/content/addiction/drugs/mouse.html